New book by Larry Connors - Click here to read more
MarketTelegraph.com is part of Stock Profiler.US, LLC's News Division. Stock Profiler welcomes investors to chat LIVE about these stocks and more on their upgraded website with FREE Investor Tools, Live Chats, and much more! Sign up now at www.stockprofiler.us. Companies who want to broadcast their message are encouraged to contact Stock Profiler.US, LLC at (603) 424-4420.
-------------------------------------------
Infinity Medical Group Inc. (PINKSHEETS: IMGR | Quote | Chart | News | PowerRating) closed at $0.105 Monday, trading 101,700 shares.
Company News- August 25, 2008: Infinity Medical Group Inc. Receives Building Permit for 18 Yonge Street Projects
Infinity Medical Group Inc. (PINKSHEETS: IMGR | Quote | Chart | News | PowerRating) is pleased to have announced yesterday that it has received the Building permit for its 18 Yonge Street project which will be home to a Rejuvena Med Spa and a Dental Implant Clinic. The 18 Yonge Street project is a commercial retail space at the bottom of a 39 storey Condominium complex an easy walk to the Waterfront, Air Canada Centre, Union Station, Financial District and the 48 storey 872 unit Maple Leaf Square Condominium. New-condominium sales in the City of Toronto were up 45.7 per cent last year, going from 13,535 units in 2006 to 19,724 in 2007 according to officials from the Building Industry and Land Development Association (BILD), announced on 2/22/2008 in a news release. Downtown Toronto is undergoing a building boom. According to an unofficial estimate assembled by National Post staff on December 19th 2007, the vertical expansion totals about 3,005 storeys, including at least 37,355 condo units. This phenomenon in Toronto's Downtown core has created an exceptional opportunity for Infinity Medical to offer its Cosmetic Medical Laser and Dental Implant services to this underserviced area of Toronto.
Receiving this permit is the next step for Infinity Medical Group in building a presence in the downtown condominium market who's demographic is exactly the same aging Baby Boomer demographic that both Rejuvena and our Dental Implant Clinics seek as clients.
About Infinity Medical Group Inc.:
Infinity Medical Group Inc. is a specialty healthcare development company focusing on the building, finance and management of cosmetic medical laser and dental implant clinics offering elective procedures.
About Dental Implants Dental implants are designed as permanent replacements for missing teeth. A dental implant is a metal post that is surgically placed into the bone under the gums. The purpose of the placement into the bone is to encourage the integration of the dental implants. The bone actually grows around the dental implant, making the tooth secure. A replacement tooth is attached to the titanium post by means of a final abutment.
About Medical Spas
Medical spa is a hybrid between a medical clinic and a day spa that operates under the supervision of medical doctor. Medical Spa Treatments include laser treatments (Lasers are medical devices used to treat a variety of conditions, including unwanted hair, uneven pigmentation, wrinkles, and broken capillaries. The word laser is an acronym for "light amplification by stimulated emission of radiation." Lasers use a direct beam of radiation that penetrates the deeper level of the skin, called the dermis, and creates a reaction), IPL (intense pulsed light) treatment, microdermabrasion, photofacials, injectables like Botox and fillers, peels and skin tightening.
-------------------------------------------
IDT (Integrated Device Technology, Inc.) (NASDAQ:IDTI) closed at $11.05 Monday, trading 2,568,300 shares.
Company News- August 26, 2008: IDT and Cakewalk to Bundle Audio Offerings to Expand Consumer Computing Audio Experience
IDT (Integrated Device Technology, Inc.) (NASDAQ:IDTI), a leading provider of essential mixed signal semiconductor solutions that enrich the digital media experience, and Cakewalk, a leading developer of powerful and easy-to-use products for music creation and recording, today announced they have entered into an exclusive agreement to improve and expand the end-consumer personal computing (PC) audio experience. By bundling the IDT proprietary High Definition HD sound graphic user interface (GUI) and audio codec, and the Cakewalk pyro Audio Creator LE product, the companies' OEM and ODM customers can in turn enhance music creation and listening experiences for PC consumers.
To read the full news release, go to www.stockprofiler.us, and click the Headline link after entering the ticker symbol.
About IDT PC Audio Solutions
IDT PC audio solutions ensure that PC systems have the highest performing audio fidelity available, while providing advanced software capability to maximize the user experience. The IDT audio portfolio includes devices that integrate from 2 to 10 channels of audio along with advanced technologies, such as integrated digital microphone interface, analog mixer, ADAT optical interface and more, while achieving the audio fidelity required for advanced Windows Logo Program compatibility. The IDT superior worldwide customer service and support also includes driver software, utilities, tools and the necessary hardware, along with audio technology specialists, to accelerate system design and enhance the audio experience.
About Cakewalk
Cakewalk is the world's leading developer of powerful, yet easy-to-use products for music creation and recording:
* Award-winning Digital Audio Workstations and Sequencers
* Integrated Music Hardware and Software Solutions
* Innovative Virtual Instruments and Effects
* Entry-level Consumer Products Millions of musicians around the world choose Cakewalk products to produce audio for the professional music, film, broadcast and video game industries. These customers include Grammy and Emmy -winning producers, composers, sound designers and engineers. We invite you to learn more about our company and products by visiting www.cakewalk.com.
About IDT With the goal of continuously improving the digital media experience, IDT integrates its fundamental semiconductor heritage with essential innovation, developing and delivering low-power, mixed-signal solutions that solve customer problems. Headquartered in San Jose, Calif., IDT has design, manufacturing and sales facilities throughout the world. IDT stock is traded on the NASDAQ Global Select Stock Market under the symbol "IDTI." Additional information about IDT is accessible at www.IDT.com.
-------------------------------------------
Allis-Chalmers Energy, Inc. (NYSE:ALY) closed at $14.12 Monday, trading 174,200 shares.
Company News- August 26, 2008: Allis-Chalmers Energy to Participate in the 2008 Lehman Brothers CEO Energy/Power Conference
Allis-Chalmers Energy, Inc. (NYSE:ALY) announced earlier today that it will be participating in the 2008 Lehman Brothers CEO Energy/Power Conference to be held September 2-4, 2008.
To read the full news release, go to www.stockprofiler.us, and click the Headline link after entering the ticker symbol.
About Allis-Chalmers
Allis-Chalmers Energy Inc. is a Houston-based multi-faceted oilfield services company. We provide services and equipment to oil and natural gas exploration and production companies, domestically primarily in Texas, Louisiana, New Mexico, Colorado, Oklahoma, Mississippi, Wyoming, Arkansas, West Virginia, offshore in the Gulf of Mexico, and internationally, primarily in Argentina and Mexico. Allis-Chalmers provides directional drilling services, casing and tubing services, underbalanced drilling, production and workover services with coiled tubing units, rental of drill pipe and blow-out prevention equipment, and international drilling and workover services. For more information, visit our website at http://www.alchenergy.com or request future press releases via email at http://www.b2i.us/irpass.asp?BzID=1233&to=ea&s=0.
-------------------------------------------
Applied Biosystems Inc. (NYSE:ABI) closed at $36.20 Monday, trading 1,043,400 shares.
Company News- August 26, 2008: Applied Biosystems Expands Sequencing-based RNA Analysis Solutions Portfolio
Earlier today Applied Biosystems Inc. (NYSE:ABI) announced the development of a sequencing-based molecular tool for the genomic analysis of whole transcriptomes, the vast collection of RNAs transcribed from a genome. This technology, which provides detailed characterization of expressed protein-encoding genes, identifies many non-coding RNAs, and includes sample multiplexing capability, is expected to be available for limited release through an early access program that will begin in November 2008. This offering will expand the company's RNA expression analysis solutions portfolio for use with its SOLiD System, the company's ultra-high-throughput genomic analysis platform.
To read the full news release, go to www.stockprofiler.us, and click the Headline link after entering the ticker symbol.
About the SOLiD System
The SOLiD System is an end-to-end genomic analysis solution comprised of a sequencing unit, a computing cluster, and data storage. The platform is based on sequencing by oligonucleotide ligation and detection. Unlike polymerase sequencing approaches, the SOLiD System utilizes a proprietary technology called stepwise ligation, which generates high-quality data for applications including: whole genome sequencing and targeted resequencing, transcriptome analysis, small RNA discovery, gene expression profiling, chromatin immunoprecipitation (ChIP), microbial and eukaryotic resequencing, digital karyotyping, medical sequencing, and genotyping, among others.
Unparalleled throughput, scalability and accuracy distinguish the SOLiD System from other next generation sequencing platforms. The system can be scaled to support a higher density of sequence per slide through bead enrichment. Beads are an integral part of the SOLiD System's open-slide format architecture, which enables the system to generate greater than 6 gigabases of sequence data per run. The SOLiD System has demonstrated runs of nearly 15 billion bases of mappable sequence data per run in customer laboratories, and has demonstrated runs of greater than 20 billion bases of mappable sequence data at Applied Biosystems' research and development facilities. The combination of the open-slide format, bead enrichment, and software algorithms provide the infrastructure for allowing it to scale to even higher throughput, without significant changes to the system's current hardware or software. The SOLiD System's unique 2-base encoding provides built-in error checking capability that distinguishes random or systematic errors from true single base changes, or single nucleotide polymorphisms (SNPs). This capability helps researchers to detect SNPs with greater than 99.94 percent sequencing accuracy.
About Applied Biosystems Inc.
Applied Biosystems Inc. (formerly known as Applera Corporation) is a global leader in the development and marketing of instrument-based systems, consumables, software, and services for academic research, the life science industry and commercial markets. Driven by its employees' belief in the power of science to improve the human condition, the company commercializes innovative technology solutions for DNA, RNA, protein and small molecule analysis. Customers across the disciplines of academic and clinical research, pharmaceutical research and manufacturing, forensic DNA analysis, and agricultural biotechnology use the company's tools and services to accelerate scientific discovery, improve processes related to drug discovery and development, detect potentially pathogenic microorganisms, and identify individuals based on DNA sources. Applied Biosystems has a comprehensive service and field applications support team for a global installed base of high-performance genetic and protein analysis solutions. Applied Biosystems Inc. is headquartered in Norwalk, CT. On June 12, 2008, Applera Corporation and Invitrogen Corporation (NASDAQ:IVGN) announced that their Boards of Directors had approved a definitive merger agreement under which Invitrogen will acquire all of the outstanding shares of Applied Biosystems stock. The merger is subject to customary closing conditions and is targeted to close in the fall of 2008. Further information regarding the merger will be provided in a joint proxy statement/prospectus to be mailed to stockholders of the company and Invitrogen. Investors and security holders are urged to read this document when it becomes available because it will contain important information. Information about Applied Biosystems, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.appliedbiosystems.com. All information in this news release is as of the date of the release, and Applied Biosystems does not undertake any duty to update this information unless required by law.
-------------------------------------------
The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. MarketTelegraph.com is a division of Stock Profiler.US, LLC's News Division, which includes but is not limited to www.stockprofiler.us, www.businessnetwire.us, www.financialbusinessnews.us, www.fastmoneytalk.com, www.associatesfortune.com, www.thewallstreetleader.com and www.daytradersdigest.com. Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.
Please consult a broker before purchasing or selling any securities mentioned herein. To view full disclaimers and terms of use, go to www.stockprofiler.us.
Keywords: Small Cap Investments, Investor Relations, I/R Services, Investment Tools, Stock Profiles, Stock Market Quotes News, Media Coverage
CONTACT: MarketTelegraph.com Tel: +1 603 424 4420 e-mail: info@stockprofiler.us WWW: http://www.markettelegraph.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
